Understanding the patient and supporter journey in cocaine use disorder.

Autor:	Leclair D; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, United States., Waye KM; Novartis BioMedical Research, Cambridge, MA, United States., Gomez-Mancilla B; Novartis BioMedical Research, Novartis Pharma AG, Basel, Switzerland.; McGill University, Montreal, QC, Canada., Kiluk BD; Yale School of Medicine, New Haven, CT, United States., Karanam AK; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Banerjee PS; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Muthusamy VS; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Maahs S; Novartis BioMedical Research, Cambridge, MA, United States.
Jazyk:	angličtina
Zdroj:	Frontiers in psychiatry [Front Psychiatry] 2024 Apr 10; Vol. 15, pp. 1230626. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).
DOI:	10.3389/fpsyt.2024.1230626
Abstrakt:	Background: There is a paucity of literature describing experiences and journey of individuals with cocaine use disorder (CUD) and supporters who care for them. The aim of this study was to understand and document the journey of individuals with current CUD, those in CUD remission, and supporters. Methods: The online bulletin board (OBB) is a qualitative tool where participants engage in an interactive discussion on a virtual forum. After completing a 15-minute screening questionnaire determining eligibility, individuals in CUD remission and supporters participated in an OBB for 60 minutes, split across 8 days over 2 weeks. Individuals with current CUD participated in a one-time virtual focus group discussion for 90 minutes. Results: Individuals in CUD remission (n=35) were from Brazil, France, Spain, the UK, and the US; those with current CUD (n=5) and supporters (n=6) were from the US. Key insights were that individuals with current CUD were seeking a 'euphoric high' that cocaine provides. Those in CUD remission described a 'euphoric high' when they first tried cocaine, but over time it became harder to re-create this feeling. Individuals in CUD remission expressed a 'rollercoaster' of emotions from when they first started using cocaine to when they stopped. Supporters were sad, isolated, and worried about a potential cocaine overdose for their loved ones with CUD. Conclusion: The study provides valuable insights into the experiences and journey of individuals with CUD and their supporters. Data generated from this study gives insights into this under-served and growing population. Competing Interests: BG-M was employed by Novartis Pharma AG at the time of this study. He is now employed by McGill University. DL, KW, AK, PB, VM, and SM were employed by Novartis. BK is a paid consultant to CBT4CBT, LLC, which provides a digital CBT program to qualified clinical providers and organizations on a commercial basis. This conflict is managed by Yale University. (Copyright © 2024 Leclair, Waye, Gomez-Mancilla, Kiluk, Karanam, Banerjee, Muthusamy and Maahs.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu